Fresenius Medical Care Ag (FMS) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket
 
Fresenius Medical Care Ag  (NYSE: FMS)
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare

Select the Financial Report: Select the Period:


Description of Fresenius Medical Care Ag's Business Segments


Fresenius Medical Care AG & Co. KGaA is a prominent global player in the kidney dialysis market, distinguished by its comprehensive portfolio of products and services tailored for patients with chronic kidney disease (CKD). The companys offerings are segmented into distinct categories that address various aspects of renal care, creating a robust ecosystem designed to improve patient outcomes and quality of life.

Segments

1. Dialysis Products and Services:
This primary segment focuses on the provision of high-quality dialysis equipment and consumables to healthcare providers worldwide. It includes:

- Dialysis Machines: These state-of-the-art devices are engineered for both in-center and home dialysis, ensuring that treatments are efficient, patient-friendly, and precise.
- Dialyzers: Often referred to as artificial kidneys, dialyzers are crucial components in the dialysis process, facilitating the removal of waste products and excess fluids from the blood.
- Dialysis Concentrates and Disposables: These products include various solutions and items necessary for dialysis treatments, ensuring that each session is effective and tailored to individual patient needs.
- Comprehensive Dialysis Services: The company provides renal dialysis services across a global footprint, delivering essential care to millions of patients. This includes both chronic and acute treatment options.

2. Renal Pharmaceuticals:
In this segment, Fresenius Medical Care offers a range of pharmaceuticals specifically designed for the treatment and management of conditions relating to kidney failure and associated complications. These include:

- Intravenous Generic Drugs: These drugs are administered to enhance the health outcomes of dialysis patients, often addressing issues such as anemia and electrolyte imbalances.

3. Care Coordination:
This segment emphasizes the importance of synchronized care among healthcare providers, with the goal of improving the treatment and management of kidney disease. Key offerings include:

- Patient Management Programs: These programs aid in tracking patients health data, ensuring timely interventions and adjustments to treatment plans.
- Collaboration Tools: Fresenius Medical Care utilizes advanced technology to enhance communication between healthcare providers, patients, and caregivers, fostering better health outcomes.

Products

1. Dialysis Machines:
Fresenius Medical Cares dialysis machines are at the forefront of technology designed to optimize treatment efficiency and patient comfort. They are equipped with advanced monitoring systems that help ensure safe and effective treatment protocols.

2. Dialyzers:
The dialyzers provided by the company feature innovative filtration systems designed to maximize biocompatibility and effectiveness, catering to the varying needs of patients undergoing dialysis.

3. Dialysis Concentrates:
These essential solutions are formulated to assist within the dialysis process, balancing electrolytes and removing toxins while ensuring patient safety during treatment.

4. Disposables:
An extensive range of disposables is manufactured to support dialysis procedures, including bloodlines, catheters, and sterile packaging for hygienic and efficient handling.

Services

1. Renal Dialysis Services:
Fresenius Medical Care operates numerous dialysis clinics globally, staffed with specialized nephrologists, nurses, and healthcare professionals dedicated to providing high-standard renal care. These clinics facilitate both in-center and outpatient services.

2. Hospital Dialysis Services:
The company partners with hospitals to set up in-house dialysis units, allowing for greater integration of care for hospitalized patients with renal issues. These services ensure continuous patient management in acute settings.

3. Home Dialysis Services:
Fresenius Medical Care promotes patient autonomy through its home dialysis services. Patients can choose from several home treatment options, including peritoneal dialysis and home hemodialysis, which offers convenience and flexibility while enhancing the overall quality of life.

4. Telemedicine and Remote Monitoring:
The company has integrated telehealth solutions into its service offerings, allowing for ongoing patient monitoring and support. This technology facilitates regular check-ins and acts as a preventive health measure.

Conclusion

Fresenius Medical Care AG & Co. KGaA stands as a leader in the renal healthcare sector, providing a comprehensive suite of dialysis products and services. Through its focus on innovation, quality, and patient-centric care, the company not only supports patients directly but also enhances the capabilities of healthcare providers and systems globally. The integration of advanced technology, pharmaceuticals, and holistic care coordination underlines Fresenius Medical Care’s commitment to addressing the challenges faced by individuals with kidney disease effectively.




Annual Report on Fresenius Medical Care Ag Divisions, Sales by Country

 
Health care services   Health care services Segment contribution to total sales 78.02 % of total Revenue
Health care products   Health care products Segment contribution to total sales 21.98 % of total Revenue
Inter-eliminations   Inter-eliminations Segment contribution to total sales -10.22 % of total Revenue
Care Delivery   Care Delivery Segment contribution to total sales 72.42 % of total Revenue
Care Delivery Segments   Care Delivery Segments Segment contribution to total sales 72.42 % of total Revenue
Care Delivery United States   Care Delivery United States Segment contribution to total sales 66.19 % of total Revenue
Care Delivery International   Care Delivery International Segment contribution to total sales 12.81 % of total Revenue
Care Enablement   Care Enablement Segment contribution to total sales 28.74 % of total Revenue
Care Enablement Segments   Care Enablement Segments Segment contribution to total sales 28.74 % of total Revenue
Care Enablement Inter-eliminations   Care Enablement Inter-eliminations Segment contribution to total sales -7.74 % of total Revenue
Total Segment   Total Segment Segment contribution to total sales 110.22 % of total Revenue
Total Health care services   Total Health care services Segment contribution to total sales 69.67 % of total Revenue
Total Health care products   Total Health care products Segment contribution to total sales 21.65 % of total Revenue
Care Delivery Health care services   Care Delivery Health care services Segment contribution to total sales 69.67 % of total Revenue
Care Delivery Health care products   Care Delivery Health care products Segment contribution to total sales 0.98 % of total Revenue
Care Enablement Health care products   Care Enablement Health care products Segment contribution to total sales 20.67 % of total Revenue
Corporate   Corporate Segment contribution to total sales -0.08 % of total Revenue
Inter-segment   Inter-segment Segment contribution to total sales 10.1 % of total Revenue
Inter-Total Segment   Inter-Total Segment Segment contribution to total sales -10.22 % of total Revenue
Inter-Care Enablement   Inter-Care Enablement Segment contribution to total sales -7.74 % of total Revenue
Germany   Germany Segment contribution to total sales 2.48 % of total Revenue
United States   United States Segment contribution to total sales 70.68 % of total Revenue
Rest of the World   Rest of the World Segment contribution to total sales 97.52 % of total Revenue
Healthcare services   Healthcare services Segment contribution to total sales 69.67 % of total Revenue
Healthcare products   Healthcare products Segment contribution to total sales 21.98 % of total Revenue
Insurance contracts   Insurance contracts Segment contribution to total sales 8.35 % of total Revenue
Care Delivery Inter-eliminations   Care Delivery Inter-eliminations Segment contribution to total sales -2.49 % of total Revenue
Care Delivery United States Segments   Care Delivery United States Segments Segment contribution to total sales 59.61 % of total Revenue
Care Delivery International Segments   Care Delivery International Segments Segment contribution to total sales 12.81 % of total Revenue
Value-Based Care   Value-Based Care Segment contribution to total sales 9.06 % of total Revenue
Value-Based Care Segments   Value-Based Care Segments Segment contribution to total sales 9.06 % of total Revenue
Total Healthcare services   Total Healthcare services Segment contribution to total sales 69.67 % of total Revenue
Total Healthcare products   Total Healthcare products Segment contribution to total sales 21.65 % of total Revenue
Care Delivery Healthcare services   Care Delivery Healthcare services Segment contribution to total sales 68.95 % of total Revenue
Care Delivery Healthcare products   Care Delivery Healthcare products Segment contribution to total sales 0.98 % of total Revenue
Value-Based Care Healthcare services   Value-Based Care Healthcare services Segment contribution to total sales 0.72 % of total Revenue
Care Enablement Healthcare products   Care Enablement Healthcare products Segment contribution to total sales 20.67 % of total Revenue
Inter-Care Delivery   Inter-Care Delivery Segment contribution to total sales -2.49 % of total Revenue


Twelve months ended 2024
FMS s Annual Revenue by Geography and Business Segments Sales
(in millions $)
%
(of total Sales)
Health care services 16,895.63 78.02 %
Health care products 4,760.58 21.98 %
Inter-eliminations -2,213.73 -10.22 %
Care Delivery 15,683.88 72.42 %
Care Delivery Segments 15,683.88 72.42 %
Care Delivery United States 14,333.71 66.19 %
Care Delivery International 2,774.42 12.81 %
Care Enablement 6,223.32 28.74 %
Care Enablement Segments 6,223.32 28.74 %
Care Enablement Inter-eliminations -1,675.23 -7.74 %
Total Segment 23,869.95 110.22 %
Total Health care services 15,087.93 69.67 %
Total Health care products 4,688.54 21.65 %
Care Delivery Health care services 15,087.93 69.67 %
Care Delivery Health care products 212.50 0.98 %
Care Enablement Health care products 4,476.04 20.67 %
Corporate -17.10 -0.08 %
Inter-segment 2,186.63 10.1 %
Inter-Total Segment -2,213.73 -10.22 %
Inter-Care Enablement -1,675.23 -7.74 %
Germany 536.44 2.48 %
United States 15,307.31 70.68 %
Rest of the World 21,119.78 97.52 %
Healthcare services 15,087.93 69.67 %
Healthcare products 4,760.58 21.98 %
Insurance contracts 1,807.71 8.35 %
Care Delivery Inter-eliminations -538.49 -2.49 %
Care Delivery United States Segments 12,909.45 59.61 %
Care Delivery International Segments 2,774.42 12.81 %
Value-Based Care 1,962.75 9.06 %
Value-Based Care Segments 1,962.75 9.06 %
Total Healthcare services 15,087.93 69.67 %
Total Healthcare products 4,688.54 21.65 %
Care Delivery Healthcare services 14,932.88 68.95 %
Care Delivery Healthcare products 212.50 0.98 %
Value-Based Care Healthcare services 155.04 0.72 %
Care Enablement Healthcare products 4,476.04 20.67 %
Inter-Care Delivery -538.49 -2.49 %
Total 21,656.22 100 %


Twelve months ended 2024
FMS s Annual Income by Country and Business Segments Income
(in millions $)
%
(Profit Margin)
Germany -30.44 -
United States 688.90 4.5 %
Total 829.77 3.83 %

Twelve months ended 2024
Annual Revenue and Income Growth by Country and Business Segments % Y/Y Sales Growth % Y/Y Income Growth
Health care services -2 % -
Health care products 4.7 % -
Inter-eliminations - -
Care Delivery -10.11 % -
Care Delivery Segments -10.11 % -
Care Delivery United States 1.05 % -
Care Delivery International -14.95 % -
Care Enablement 3.95 % -
Care Enablement Segments 3.95 % -
Care Enablement Inter-eliminations - -
Total Segment 1.86 % -
Total Health care services -4.91 % -
Total Health care products 5.2 % -
Care Delivery Health care services -4.91 % -
Care Delivery Health care products 3.1 % -
Care Enablement Health care products 5.31 % -
Corporate - -
Inter-segment 33.99 % -
Inter-Total Segment - -
Inter-Care Enablement - -
Germany -1.09 % -
United States 1.19 % -5.09 %
Rest of the World 245.17 % -



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.